SOX17 Antikörper (AA 177-414)

Produktnummer ABIN2732433

Produktdetails anti-SOX17 Antikörper

Target: SOX17 (SRY (Sex Determining Region Y)-Box 17 (SOX17))

Bindungsspezifität: AA 177-414

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser SOX17 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)

Aufreinigung: Purified from mouse ascites fluids by affinity chromatography

Immunogen: Human recombinant protein fragment corresponding to amino acids 177-414 of human SOX17 (NP_071899) produced in E.coli.

Klon: 3B10

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: WB 1:5000, IHC 1:50, IF 1:50~100, FLOW 1:100

Kommentare:

The concentration of the product may vary between diferrent lots.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5-1.0 mg/mL

Buffer: PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Referenzen für anti-SOX17 Antikörper (ABIN2732433)

Imamura, Fujita, Tagawa, Ikura, Chen, Homma, Tamura, Mao, Taniguchi, Motoki, Nakabayashi, Ito, Yamada, Tomii, Okano, Kaye, Finkbeiner, Okazawa: "Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries." in: Scientific reports, Vol. 6, pp. 33861, (2016) (PubMed).

Takeuchi, Nakatsuji, Suemori: "Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture." in: Scientific reports, Vol. 4, pp. 4488, (2014) (PubMed).

Pennarossa, Maffei, Campagnol, Tarantini, Gandolfi, Brevini: "Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 22, pp. 8948-53, (2013) (PubMed).

Zhang, Cruz, Terry, Remotti, Matushansky: "Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming." in: Oncogene, Vol. 32, Issue 18, pp. 2249-60, 2260.e1-21, (2013) (PubMed).

Details zu SOX17

Target: SOX17 (SRY (Sex Determining Region Y)-Box 17 (SOX17))

Andere Bezeichnung: SOX17 (SOX17 Produkte)

Synonyme: VUR3 antikoerper, SOX17 antikoerper, Sox17alpha antikoerper, Xsox17 antikoerper, Xsox17-alpha antikoerper, Xsox17alpha antikoerper, sox17-alpha antikoerper, tSox17alpha antikoerper, xSox17alpha1 antikoerper, xSox17alpha2 antikoerper, xsox17a antikoerper, sox17 antikoerper, sox7/17 antikoerper, Sox antikoerper, SRY-box 17 antikoerper, SRY (sex determining region Y)-box 17 antikoerper, SRY box 17 antikoerper, SRY-box 17 alpha antikoerper, sox7/17 protein antikoerper, SOX17 antikoerper, sox17 antikoerper, Sox17 antikoerper, sox17a antikoerper, sox7/17 antikoerper

Molekulargewicht: 43.9 kDa

Gen-ID: 64321

NCBI Accession: NM_022454

HGNC: 64321